Search research articles
Contact Us
Filters
Showing results (11-20 of 74) with videos related to
Page
of 8
Sort By:
Breast Cancer Research and Treatment
|
May 30, 2020
Cumulative incidence of chemotherapy-induced cardiotoxicity during a 2-year follow-up period in breast cancer patients
Hyunsoon Cho, Sanghee Lee, Sung Hoon Sim, et al.
Journal of Cancer
|
April 21, 2018
Phase I/II clinical trial of everolimus combined with gemcitabine/cisplatin for metastatic triple-negative breast cancer
In Hae Park, Sun-Young Kong, Youngmee Kwon, et al.
Journal of Breast Cancer
|
February 26, 2021
Palbociclib Plus Fulvestrant in Korean Patients from PALOMA-3 With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer
Jee Hyun Kim, Seock Ah Im, Sung Hoon Sim, et al.
Journal of Cancer Research and Clinical Oncology
|
July 10, 2014
The gefitinib dose reduction on survival outcomes in epidermal growth factor receptor mutant non-small cell lung cancer
Sung Hoon Sim, Bhumsuk Keam, Dong-Wan Kim, et al.
Cancer Science
|
November 24, 2011
Influence of chemotherapy on nitric oxide synthase, indole-amine-2,3-dioxygenase and CD124 expression in granulocytes and monocytes of non-small cell lung cancer
Sung Hoon Sim, Yong-Oon Ahn, Jieun Yoon, et al.
Biology
|
November 13, 2020
The Tumor-Fat Interface Volume of Breast Cancer on Pretreatment MRI Is Associated with a Pathologic Response to Neoadjuvant Chemotherapy
Hwan-Ho Cho, Minsu Park, Hyunjin Park, et al.
JMIR Public Health and Surveillance
|
March 8, 2023
Surveillance of Symptom Burden Using the Patient-Reported Outcome Version of the Common Terminology Criteria for Adverse Events in Patients With Various Types of Cancers During Chemoradiation Therapy: Real-World Study
Danbee Kang, Sooyeon Kim, Hyunsoo Kim, et al.
Thoracic Cancer
|
April 5, 2016
Pretreatment neutrophil-lymphocyte ratio is not a significant prognostic factor in epidermal growth factor receptor-mutant non-small cell lung cancer patients treated with tyrosine kinase inhibitors
Sung Hoon Sim, Seung-Hoon Beom, Yong-Oon Ahn, et al.
Cancer Research and Treatment
|
September 3, 2016
A Rare Case of Phyllodes Tumor Metastasis to the Stomach Presenting as Anemia
Do Il Choi, Ho Seok Chi, Sang Ho Lee, et al.
Molecular Cancer Research : MCR
|
November 10, 2019
Genomic Characteristics of Triple-Negative Breast Cancer Nominate Molecular Subtypes That Predict Chemotherapy Response
Jihyun Kim, Doyeong Yu, Youngmee Kwon, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 74) with videos related to
Sort By:
Page
of 8
Breast Cancer Research and Treatment
|
May 30, 2020
Cumulative incidence of chemotherapy-induced cardiotoxicity during a 2-year follow-up period in breast cancer patients
Hyunsoon Cho, Sanghee Lee, Sung Hoon Sim, et al.
Journal of Cancer
|
April 21, 2018
Phase I/II clinical trial of everolimus combined with gemcitabine/cisplatin for metastatic triple-negative breast cancer
In Hae Park, Sun-Young Kong, Youngmee Kwon, et al.
Journal of Breast Cancer
|
February 26, 2021
Palbociclib Plus Fulvestrant in Korean Patients from PALOMA-3 With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer
Jee Hyun Kim, Seock Ah Im, Sung Hoon Sim, et al.
Journal of Cancer Research and Clinical Oncology
|
July 10, 2014
The gefitinib dose reduction on survival outcomes in epidermal growth factor receptor mutant non-small cell lung cancer
Sung Hoon Sim, Bhumsuk Keam, Dong-Wan Kim, et al.
Cancer Science
|
November 24, 2011
Influence of chemotherapy on nitric oxide synthase, indole-amine-2,3-dioxygenase and CD124 expression in granulocytes and monocytes of non-small cell lung cancer
Sung Hoon Sim, Yong-Oon Ahn, Jieun Yoon, et al.
Biology
|
November 13, 2020
The Tumor-Fat Interface Volume of Breast Cancer on Pretreatment MRI Is Associated with a Pathologic Response to Neoadjuvant Chemotherapy
Hwan-Ho Cho, Minsu Park, Hyunjin Park, et al.
JMIR Public Health and Surveillance
|
March 8, 2023
Surveillance of Symptom Burden Using the Patient-Reported Outcome Version of the Common Terminology Criteria for Adverse Events in Patients With Various Types of Cancers During Chemoradiation Therapy: Real-World Study
Danbee Kang, Sooyeon Kim, Hyunsoo Kim, et al.
Thoracic Cancer
|
April 5, 2016
Pretreatment neutrophil-lymphocyte ratio is not a significant prognostic factor in epidermal growth factor receptor-mutant non-small cell lung cancer patients treated with tyrosine kinase inhibitors
Sung Hoon Sim, Seung-Hoon Beom, Yong-Oon Ahn, et al.
Cancer Research and Treatment
|
September 3, 2016
A Rare Case of Phyllodes Tumor Metastasis to the Stomach Presenting as Anemia
Do Il Choi, Ho Seok Chi, Sang Ho Lee, et al.
Molecular Cancer Research : MCR
|
November 10, 2019
Genomic Characteristics of Triple-Negative Breast Cancer Nominate Molecular Subtypes That Predict Chemotherapy Response
Jihyun Kim, Doyeong Yu, Youngmee Kwon, et al.
Page
of 8